Market Capitalization of Concord Drugs (CONCORD)
As of May 21, 2026, Concord Drugs (CONCORD) market capitalisation is ₹106.69 Cr ($11.85M), with 1.33 Cr shares outstanding at a current price of ₹80.00 on BSE, ranking 3093 out of 5362 companies by market cap in our screener. Concord Drugs operates in the Healthcare sector and is classified as a Small Cap stock. For live price, earnings and the complete company profile, see Concord Drugs share price today.
Market Cap History of Concord Drugs (Last 10 Years)
CONCORD market capitalisation from year-end BSE closing prices over the last 10 years. Read Concord Drugs dividend policy for the complete payout history and dividend yield track record.
End of Year Market Cap History — Concord Drugs
CONCORD year-end market cap in INR and USD with closing share price and annual change — BSE closing prices. Analyse Concord Drugs ownership structure to track promoter, FII and institutional holdings.
| Year | Market Cap | Share Price | Exchange | Change |
|---|---|---|---|---|
| 2026 |
₹106.69 Cr
$11.85M USD
|
₹80.00 | BSE | -3.01% |
| 2025 |
₹110.00 Cr
$12.22M USD
|
₹82.48 | BSE | +118.78% |
| 2024 |
₹50.28 Cr
$5.59M USD
|
₹37.70 | BSE | -36.87% |
| 2023 |
₹79.64 Cr
$8.85M USD
|
₹59.72 | BSE | +83.47% |
| 2022 |
₹43.41 Cr
$4.82M USD
|
₹32.55 | BSE | +1.24% |
| 2021 |
₹42.88 Cr
$4.76M USD
|
₹32.15 | BSE | +40.39% |
| 2020 |
₹30.54 Cr
$3.39M USD
|
₹22.90 | BSE | +52.67% |
| 2019 |
₹20.00 Cr
$2.22M USD
|
₹15.00 | BSE | -33.63% |
| 2018 |
₹30.14 Cr
$3.35M USD
|
₹22.60 | BSE | -29.38% |
| 2017 |
₹42.68 Cr
$4.74M USD
|
₹32.00 | BSE | -34.69% |
| 2016 |
₹65.35 Cr
$7.26M USD
|
₹49.00 | BSE | -17.72% |
| 2015 |
₹79.42 Cr
$8.82M USD
|
₹59.55 | BSE | - |